glp-1 medications and anesthesia A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general The Impact of GLP-1 Receptor

CMS calls off program to cover GLP-1s April 23, 2026 Summary: CMS has indefinitely postponed its BALANCE program that would have subsidized GLP-1 obesity medications for Medicare members, a predictable outcome given the adverse selection risks and short-term cost challenges that make coverage financially untenable for health plans even at negotiated prices

Lets rule out other causes

If you are starting tirzepatide for weight loss under the care of our providers, you may be wondering when you can expect to see results

Metagenomics of Parkinsons disease implicates the gut microbiome in multiple disease mechanisms

Manage your Ozempic, Wegovy, Mounjaro, and Zepbound injections with smart reminders, progress analytics, and side-effect tracking - all in one app

For acute detoxification needs (post-illness, after heavy alcohol consumption, environmental exposure), a single session provides immediate benefit